Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NeuPath Health Inc V.NPTH

NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. The Company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain... see more

TSXV:NPTH - Post Discussion

NeuPath Health Inc > Webinar w NeuPath CEO Grant Connelly Wed Dec 22 @ 2PM ET
View:
Post by bmreed on Dec 16, 2021 2:05pm

Webinar w NeuPath CEO Grant Connelly Wed Dec 22 @ 2PM ET

Webinar - NeuPath Health (NPTH) w/ CEO Grant Connelly

Wed, Dec 22 at 2pm ET / 11am PT

Q&A with Radius Research 

Register Here - https://us02web.zoom.us/webinar/register/2616396704523/WN_H19HXfPpTFynresaqjA7Mg

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities